SLNO Q4 2018 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SLNOSoleno Therapeutics, Inc.

$2B

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$4M

Net Income

$263,000

EPS (Diluted)

$0.15

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$257,000

Balance Sheet

Total Assets

$43M

Total Liabilities

$13M

Stockholders' Equity

$30M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$735M	-100.0%
Gross Profit	$0	-$85M	+100.0%
Operating Income	-$4M	-$5M	+32.0%
Net Income	$263,000	-$5M	+105.2%